CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Sympathetic skin response (SSR) measureother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03870295
NCT03870295N/ACompleted

Assessment of a New Measurement Technique for Type C Fibre Nerve Conduction Velocity in Polyneuropathies.

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer·interventional·Posted Mar 12, 2019·Updated Oct 13, 2022

In Brief

A clinical study evaluating Sympathetic skin response (SSR) measure for Peripheral Nervous System Diseases. Completed, enrolled 45 participants across 1 site.

Detailed Summary

Peripheral nerve diseases can separately affect different kind of nerve fibres. Globally two kinds of fibres can be distinguished: large size and small size. The usual electromyogram only investigates large size fibres. Techniques to explore small size fibre function exist but are not used in common practice because of their very specialized aspect or their lack of diagnostic value. The purpose of this study is to develop a measurement technique of small size type C nerve fibre conduction velocity, to show that this velocity is reduced in patients suffering from polyneuropathies and to establish reference values in healthy patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 12, 2019
Enrollment StartSep 30, 2019
Primary CompletionSep 29, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.3 years ago

Interventions

Sympathetic skin response (SSR) measureother

Ankle - ground distance measurement, hand and foot cutaneous temperature reading, low intensity electrical stimulations on hand and on foot to determine SSR at these two points and DN4 questionnaire to assess the possible presence of neuropathic pain